Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+827.3%
5Y CAGR+196.4%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+827.3%/yr
vs -50.6%/yr prior
5Y CAGR
+196.4%/yr
Recent acceleration
Acceleration
+877.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
228.9x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$3.79M+100.1%
2024$1.89M+261.8%
2023$523000.00+10915.2%
2022$4748.00-98.1%
2021$253883.00+1435.1%
2020$16539.00-89.7%
2019$160901.00+101.5%
2018$79835.00-78.2%
2017$366216.00-52.1%
2016$764735.00-